<scp>O</scp> rkambi® and amplifier co‐therapy improves function from a rare <i> <scp>CFTR</scp> </i> mutation in gene‐edited cells and patient tissue
2017 · EMBO Molecular Medicine · 105 citations
https://doi.org/10.15252/emmm.201607137
W
Wan Ip
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
49
Papers
1.6K
Citations
22
h-index
30
i10-index
Wan Ip is an academic researcher from University of Macau. The author has contributed to research in topics: Cystic Fibrosis Research Advances & Neonatal Respiratory Health Research & Blood disorders and treatments. The author has an h-index of 22, co-authored 42 publications.
ORCID: 0000-0001-9668-4360Papers by this author
worksPhenotypic profiling of CFTR modulators in patient-derived respiratory epithelia
2017 · npj Genomic Medicine · 89 citations
https://doi.org/10.1038/s41525-017-0015-6
Inhibition of corticotropin-releasing hormone receptor 1 and activation of receptor 2 protect against colonic injury and promote epithelium repair
2017 · Scientific Reports · 59 citations
https://doi.org/10.1038/srep46616
CFTR interactome mapping using the mammalian membrane two‐hybrid high‐throughput screening system
2022 · Molecular Systems Biology · 28 citations
https://doi.org/10.15252/msb.202110629
Exocrine Pancreatic Alterations in Long-Lived Surviving Cystic Fibrosis Mice
1996 · Pediatric Research · 26 citations
https://doi.org/10.1203/00006450-199608000-00009
Testing gene therapy vectors in human primary nasal epithelial cultures
2015 · Molecular Therapy — Methods & Clinical Development · 26 citations
https://doi.org/10.1038/mtm.2015.34
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat